Your browser doesn't support javascript.
loading
[Cost Comparison of Licensed Intravitreal Therapies for Insufficiently Anti-VEGF Responding Fovea Involving Diabetic Macular Edema in Germany]. / Kostenvergleich zugelassener intravitrealer Therapien bei nicht ausreichend auf primäre Therapie ansprechendem diabetischem Makulaödem mit fovealer Beteiligung in Deutschland.
Neubauer, Aljoscha S; Haritoglou, Christos; Ulbig, Michael W.
Affiliation
  • Neubauer AS; Praxis für Augenheilkunde und Institut für Gesundheitsökonomie (IfG), München.
  • Haritoglou C; Augenklinik Herzog Carl Theodor, München.
  • Ulbig MW; Augenklinik, Klinikum rechts der Isar der Technischen Universität München.
Klin Monbl Augenheilkd ; 236(2): 180-191, 2019 Feb.
Article in De | MEDLINE | ID: mdl-29452450
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluocinolone Acetonide / Macular Edema / Vascular Endothelial Growth Factor A / Diabetic Retinopathy / Drug Implants / Glucocorticoids Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limits: Humans Country/Region as subject: Europa Language: De Journal: Klin Monbl Augenheilkd Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluocinolone Acetonide / Macular Edema / Vascular Endothelial Growth Factor A / Diabetic Retinopathy / Drug Implants / Glucocorticoids Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limits: Humans Country/Region as subject: Europa Language: De Journal: Klin Monbl Augenheilkd Year: 2019 Document type: Article